Expert panel seeks safety data for Russia's Sputnik V Covid-19 vaccine before emergency use nod

Expert panel seeks safety data for Russia's Sputnik V Covid-19 vaccine before emergency use nod

India Today

Days after Dr Reddy's Laboratories applied for emergency use authorisation (EUA) of Russia's Covid-19 vaccine Sputnik V, an expert panel of the Central Drug Authority on Wednesday asked the firm to submit more immunogenicity and safety data.

As part of the review process, the Hyderabad-headquartered firm presented the safety profile of the Phase 2 study conducted on Sputnik V as well as interim data of its Phase 3 study.

Dr Reddy's Laboratories began testing the vaccine, developed by Moscow's Gamaleya National Research Institute, in India on around 1,500 participants last December.

Disclaimer: This is an automatically aggregated article/story by a computer program and has not been created or edited by Newsdig.in.

World COVID19 Meter

142978261

Cases

121673362

Recovered

3044588

Deaths
Last updated: GMT
Advt
Advt
Advt
sitemap Disclaimer
Newsdig.in 2019